588 related articles for article (PubMed ID: 33157015)
1. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT; Kaiser AM; Morgens DW; Boutelle AM; Seoane JA; Van Nostrand EL; Zhu C; Houlihan SL; Mello SS; Yee BA; McClendon J; Pierce SE; Winters IP; Wang M; Connolly AJ; Lowe SW; Curtis C; Yeo GW; Winslow MM; Bassik MC; Attardi LD
Mol Cell; 2020 Nov; 80(3):452-469.e9. PubMed ID: 33157015
[TBL] [Abstract][Full Text] [Related]
2. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
3. Zmat3 splices together p53-dependent tumor suppression.
Bieging-Rolett KT; Attardi LD
Mol Cell Oncol; 2021; 8(3):1898523. PubMed ID: 34027039
[TBL] [Abstract][Full Text] [Related]
4. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Best SA; Vandenberg CJ; Abad E; Whitehead L; Guiu L; Ding S; Brennan MS; Strasser A; Herold MJ; Sutherland KD; Janic A
Cell Death Dis; 2020 Oct; 11(10):877. PubMed ID: 33082333
[TBL] [Abstract][Full Text] [Related]
5. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.
Brennan MS; Brinkmann K; Romero Sola G; Healey G; Gibson L; Gangoda L; Potts MA; Lieschke E; Wilcox S; Strasser A; Herold MJ; Janic A
Cell Death Differ; 2024 Feb; 31(2):159-169. PubMed ID: 38110554
[TBL] [Abstract][Full Text] [Related]
6. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
8. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
9. Identification of nonsense-mediated mRNA decay pathway as a critical regulator of p53 isoform β.
Cowen LE; Tang Y
Sci Rep; 2017 Dec; 7(1):17535. PubMed ID: 29235495
[TBL] [Abstract][Full Text] [Related]
10. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.
Escobar-Hoyos LF; Penson A; Kannan R; Cho H; Pan CH; Singh RK; Apken LH; Hobbs GA; Luo R; Lecomte N; Babu S; Pan FC; Alonso-Curbelo D; Morris JP; Askan G; Grbovic-Huezo O; Ogrodowski P; Bermeo J; Saglimbeni J; Cruz CD; Ho YJ; Lawrence SA; Melchor JP; Goda GA; Bai K; Pastore A; Hogg SJ; Raghavan S; Bailey P; Chang DK; Biankin A; Shroyer KR; Wolpin BM; Aguirre AJ; Ventura A; Taylor B; Der CJ; Dominguez D; Kümmel D; Oeckinghaus A; Lowe SW; Bradley RK; Abdel-Wahab O; Leach SD
Cancer Cell; 2020 Aug; 38(2):198-211.e8. PubMed ID: 32559497
[TBL] [Abstract][Full Text] [Related]
11. PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA.
Yano K; Takahashi RU; Shiotani B; Abe J; Shidooka T; Sudo Y; Yamamoto Y; Kan S; Sakagami H; Tahara H
J Biol Chem; 2021 Jul; 297(1):100882. PubMed ID: 34144037
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract][Full Text] [Related]
14. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.
Yuan JH; Liu XN; Wang TT; Pan W; Tao QF; Zhou WP; Wang F; Sun SH
Nat Cell Biol; 2017 Jul; 19(7):820-832. PubMed ID: 28553938
[TBL] [Abstract][Full Text] [Related]
15. SRSF2 Regulation of
Comiskey DF; Montes M; Khurshid S; Singh RK; Chandler DS
Mol Cancer Res; 2020 Feb; 18(2):194-203. PubMed ID: 31662450
[No Abstract] [Full Text] [Related]
16. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.
He X; Liu F; Yan J; Zhang Y; Yan J; Shang H; Dou Q; Zhao Q; Song Y
Sci Rep; 2015 Mar; 5():8705. PubMed ID: 25732051
[TBL] [Abstract][Full Text] [Related]
17. Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation.
Yan W; Scoumanne A; Jung YS; Xu E; Zhang J; Zhang Y; Ren C; Sun P; Chen X
Genes Dev; 2016 Mar; 30(5):522-34. PubMed ID: 26915821
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency for Core Exon Junction Complex Components Disrupts Embryonic Neurogenesis and Causes p53-Mediated Microcephaly.
Mao H; McMahon JJ; Tsai YH; Wang Z; Silver DL
PLoS Genet; 2016 Sep; 12(9):e1006282. PubMed ID: 27618312
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
Gudikote JP; Cascone T; Poteete A; Sitthideatphaiboon P; Wu Q; Morikawa N; Zhang F; Peng S; Tong P; Li L; Shen L; Nilsson M; Jones P; Sulman EP; Wang J; Bourdon JC; Johnson FM; Heymach JV
J Biol Chem; 2021 Nov; 297(5):101163. PubMed ID: 34481841
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor DHX15 affects tp53 and mdm2 expression via alternate splicing and promoter usage.
McElderry J; Carrington B; Bishop K; Kim E; Pei W; Chen Z; Ramanagoudr-Bhojappa R; Prakash A; Burgess SM; Liu PP; Sood R
Hum Mol Genet; 2019 Dec; 28(24):4173-4185. PubMed ID: 31691804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
